Feed NATCOPHARM.BO
NA
NATCO Pharma Limited
NATCOPHARM.BO · BSE
₹900.05 +1.16% (+₹10.35)
1M -5.64%
Market Cap ₹161.2B
P/E Ratio 11.36x
Div. Yield -
ROE 17.96%
Bulios Fair Price
₹1,090
21.1% upside
Preț actual
₹900.05
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NATCOPHARM.BO sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
2/9Valuation
87 /100
Cheap P/FCF 11.71x
P/E 11.36x
P/B 1.75x
Growth
93 /100
Growing Book val. growth 23.68%
Rev. growth 14.62%
FCF growth 28.87%
Profitability
100 /100
Strong Op. margin 30.16%
Gross margin 83.07%
FCF margin 33.77%
Quality
69 /100
Excellent ROA 12.81%
ROIC 11.32%
Asset turnover 0.37x
Debt
100 /100
Low Int. coverage 41.62x
Debt/Equity 0.08x
Net debt/EBITDA 0.30x
Stability
25 /100
Unstable EPS volatility 101.03%
Beta 0.12x
Profitable years 6
Întreabă StockBot despre NATCOPHARM.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rajeev Nannapaneni
Employees
4,199
Headquarters
Hyderabad
Evenimente viitoare
20 AUG.
Ex-Dividend
Ex-dividend date
26 AUG.
Dividend Payment
Data plății
17 NOV.
Earnings
Upcoming earnings report